CBIO
#2742
Crescent Biopharma, Inc. - Common Stock
17.7 5 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.06%
Variación mensual
+21.08%
Variación en los últimos 6 meses
+56.66%
Cambio anual
+22.50%
Cierres anteriores
17.7 6
Open
17.7 5
Mínimo
17.7 5
Máximo
17.7 5
Volumen
31
Financials
- Market Capitalization 659.3 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
1.75
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2021 |  GENB Generate Biomedicines, Inc. - Common Stock | 15.33 USD | -2.79% | -8.53% | +16.93% | +2.20% | 1.97 B USD | ||
| 2181 |  MAZE Maze Therapeutics, Inc. - Common Stock | 27.44 USD | -4.06% | -6.25% | -0.11% | -39.06% | 1.52 B USD | ||
| 2815 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.98 USD | -4.69% | -4.69% | +21.33% | -35.60% | 594.73 M USD | ||
| 2986 |  QTTB Q32 Bio Inc. - Common Stock | 15.03 USD | -6.93% | -9.24% | +2.87% | +810.91% | 447.44 M USD |